A comprehensive <scp>AI</scp>‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and agingFrank W. Pun, Alex Zhavoronkov, Chun Wai Wong et al.|Aging Cell|2023Cited by 40
Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinomaSankar Jagadeeshan, Ari J. Rosenberg|Oral Oncology|2024Cited by 6
NBTXR3 Activated by Radiotherapy in Combination With Nivolumab or Pembrolizumab in Patients With Advanced Cancers: A Phase I TrialColette J. Shen, Tanguy Y. Seiwert, Jessica M. Frakes et al.|International Journal of Radiation Oncology*Biology*Physics|2021Cited by 1
Safety of NBTXR3 Radioenhancer Delivery in Liver MetastasesB.D. Facer, É. Chajon, Changyu Shen et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 0